Treatment of Murine Gliomas by Adoptive Transfer ofex VivoActivated Tumor-Draining Lymph Node Cells
- 15 June 1997
- journal article
- Published by Elsevier in Cellular Immunology
- Vol. 178 (2) , 101-107
- https://doi.org/10.1006/cimm.1997.1140
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover.The Journal of cell biology, 1996
- Prolonged survival of mice with glioma injected intracerebrally with double cytokine—secreting cellsJournal of Neurosurgery, 1995
- Adoptive Immunotherapy of Murine Intracerebral Tumors with Anti-CD3/Interleukin-2-Activated Tumor-Draining Lymph Node CellsJournal of Immunotherapy, 1994
- Turnover of naive- and memory-phenotype T cells.The Journal of Experimental Medicine, 1994
- Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma.The Journal of Experimental Medicine, 1993
- Antitumor activity against established intracerebral gliomas exhibited by cytotoxic T lymphocytes, but not by lymphokine-activated killer cellsJournal of Neurosurgery, 1992
- Successful Treatment of a Malignant Rat Glioma with Cytotoxic T LymphocytesNeurosurgery, 1992
- Effect of the expression of transforming growth factor-β2 in primary human glioblastomas on immunosuppression and loss of immune surveillanceJournal of Neurosurgery, 1992
- Treatment of murine primary brain tumors with systemic interleukin-2 and tumor-infiltrating lymphocytesJournal of Neurosurgery, 1992
- A New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating LymphocytesScience, 1986